4/A

PRIMARY DOCUMENT

Company: PALVELLA THERAPEUTICS, INC.
Filed: February 10, 2025
Period of Report: February 5, 2025
Accession Number: 0001583648-25-000023

View Document ↗ View on SEC.gov ↗